Effective Medical Test Suggestions Using Deep Reinforcement Learning by Chen, Yang-En et al.
Effective Medical Test Suggestions
Using Deep Reinforcement Learning
Yang-En Chen
HTC Research & Healthcare
yangen_chen@htc.com
Kai-Fu Tang
HTC Research & Healthcare
kevin_tang@htc.com
Yu-Shao Peng
HTC Research & Healthcare
ys_peng@htc.com
Edward Y. Chang
Stanford University
eyuchang@gmail.com
Abstract
Effective medical test suggestions benefit both patients and physicians to conserve
time and improve diagnosis accuracy. In this work, we show that an agent can
learn to suggest effective medical tests. We formulate the problem as a stage-wise
Markov decision process and propose a reinforcement learning method to train
the agent. We introduce a new representation of multiple action policy along
with the training method of the proposed representation. Furthermore, a new
exploration scheme is proposed to accelerate the learning of disease distributions.
Our experimental results demonstrate that the accuracy of disease diagnosis can be
significantly improved with good medical test suggestions.
1 Introduction
Artificial intelligence for medical test suggestions benefits our society in many ways. For instance, an
automated system for suggesting medical tests can save a patient’s time. A patient often spends a
long time waiting to see a physician. Once the patient is able meet with the physician, they are then
required to take medical tests and schedule another appointment to review their results and diagnosis.
Artificial intelligence can expedite this process by enabling patients to take the system-suggested
medical tests before their appointment with a doctor. The system can suggest one or more medical
tests. If the system only suggests one medical test at a time, a patient may need to make multiple
visits to the hospital to complete their tests and follow up with doctors. A better approach is for a
system to be capable of suggesting a set of medical tests at once to reduce the number of visits a
patient must make to the hospital, which can be time consuming.
In this paper, we consider the medical tests that generate numeric results (e.g., blood tests, urine tests,
liver function testing, etc.) and do not include the radiologic tests, which involve medical images.
To simulate the most common scenario in which doctors suggest medical tests, the procedure of an
automated system is designed to follow a sequential order. The automated system first makes several
symptom queries and then suggests multiple medical tests to disambiguate plausible hypotheses. Each
symptom query should consider the answers to the previous queries to collect maximal information
from a patient. Once the automated system has exhausted productive queries, it suggests a set of
medical tests that are expected to further improve diagnosis accuracy.
We consider the process of querying symptoms and suggesting medical tests to achieve a precise
diagnosis to be an active feature acquisition problem. Many algorithms for active feature acquisition
have been proposed. For instance, Bilgic and Getoor [1] proposed a graphical model which considers
non-myopic feature acquisition strategies. Kanani and Melville [4] addressed the feature acquisition
problem for induction time. Xu et al. [13], Kusner [6], and Nan and Saligrama [9] proposed decision
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tree related methods to select key features. Recently, Janisch et al. [3] proposed a reinforcement
learning (RL) approach to learn a query strategy. Their experimental results showed that the RL
methods outperform other non-RL methods.
We formulate the medical test suggestion problem as a stage-wise Markov decision process and
propose a reinforcement learning method to learn a strategy that can suggest multiple medical tests
at a time. In traditional reinforcement learning, the agent only performs an action at a time step so
it cannot learn to suggest multiple medical tests at once. We propose a representation for multiple
action policy and a method for its training. Moreover, reinforcement learning methods are inefficient
especially when the action space is large. We propose the label-guided exploration to speed up the
learning process. We can access correct disease labels during the training process, so we use the
label information to design an efficient learning algorithm. The agent can suggest key medical tests
to facilitate disease diagnosis when both these enhancements are used. The experimental results
indicate that our agent suggests an average of 4.77 medical tests and achieves 89.75% top-5 accuracy
in disease diagnosis in the case of 200 diseases.
2 Stage-Wise Markov Decision Processes
Here, we formally define our sequential decision making problem as a finite-horizon, discounted
Markov Decision Process (MDP). An MDPM is a five tuple (S,A, p, r, γ), where set S is the state
space, set A is the action space, function p is the transition mechanism, function r is the reward
distribution, and scalar γ is the discount factor. Denote the agent’s policy by pi. Given the state s,
the agent selects an action a with the probability pi(s, a). When the agent performs an action at state
st at time step t, it receives reward rt generated by the MDP and transitions to the next state st+1.
Assuming an episode terminates at time step T , we define the return of the agent at time step t as
Rt =
∑T
i=t γ
i−tri. The objective of the agent is to find a policy that maximizes the expected return.
Stages. In this work, we partition an episode of an MDP into stages, which forms the stage-wise
MDP. The stage-wise MDP possesses two properties. First, the agent can only choose actions from
a specific action set in a given stage. With this constraint, the agent focuses on a subset of actions
in each stage. Therefore, the action space is reduced, leading to more efficient learning. Second,
the agent is limited to following a sequential order to traverse different stages. Since this limitation
significantly reduces the possible sequences of actions, the search space becomes smaller. Therefore,
the agent can explore a better sequence of actions with higher probability. In this work, an episode
is partitioned into three stages: the symptom query stage esym, the medical test suggestion stage
emed, and the disease prediction stage edis. We detail our stage-wise Markov decision process in the
following paragraphs.
States. Denote a patient by x, which is a random variable sampled from all patients. At time step t,
the state s is a four tuple s = (Ft, x, t, e). The set Ft is the information obtainable at the state. The
agent can only access the values of the information listed in Ft. We record the time step t in the state,
and the stage flag e ∈ {esym, emed, edis} indicates the state’s stage.
In this work, the set F of information items considers the demographic information items T , the
symptoms U , and the medical test results V . For a patient x and an information item f ∈ T ∪ U ∪ V ,
we use the notation f(x) to refer to the value of f on the patient x. We say that a symptom f ∈ U
is present on a patient x if f(x) = 1 and is absent if f(x) = −1. We also discretize the abnormal
results of medical tests into categories and assign a positive integer to each category. Therefore,
we say that a medical test f ∈ V obtains a normal result on a patient x if f(x) = −1 and gets an
abnormal result if f(x) is a positive integer.
Initial States. Every episode starts with an initial state satisfying the following conditions: (1) all
demographic information T is known; (2) one of the present symptoms of the patient is given; (3) all
the other information of the patient is unknown; (4) the state is in the symptom query stage. Formally,
an initial state s0 = (F0, x, t, e) satisfies
t = 0 and e = esym and ∃f ∈ U . [F0 = T ∪ {f} and f(x) = 1].
Actions. The actions of our problem can be categorized into three types: querying a symptom,
suggesting a medical test, and predicting a disease, denoted by Asym, Amed, and Adis, respectively.
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These three action sets represent the action spaces of the three stages esym, emed, and edis. Every
symptom query in the action set Asym targets a different symptom, and each action in Adis predicts a
different disease. The actions in Amed correspond to all medical tests in V . Note that the agent shall
suggests multiple medical tests at once, so it selects a subset of actions Λ ⊆ Amed to perform when
suggesting medical tests.
We add two actions q1 and q2 into Asym in the symptom query stage so the agent can manage the
timing to quit the stage. The action q1 takes the agent to the medical test suggestion stage, and the
action q2 allows the agent to bypass test suggestions and enter the disease prediction stage.
In the symptom query stage, the agent can query a symptom or quit the stage. At a state st =
(Ft, x, t, esym), if the agent queries a symptom f , the transition to the next state st+1 is defined as
Ft+1 = Ft ∪ {f}, st+1 = (Ft+1, x, t+ 1, esym).
When the agent performs the action q1 or q2 at the state st = (F , x, t, esym) to quit the symptom
query stage, the next state will be (F , x, t+ 1, emed) or (F , x, t+ 1, edis). Note that F does not gain
new information through the transition, and the stage flag of the state is set to emed or edis to indicate
that the state has transitioned to the new stage.
In the medical test suggestion stage, the agent must select a set of medical tests from the power set
2V . After the agent suggests a set of medical testsW ⊆ V at a state st = (Ft, x, t, emed), the agent
obtains the results of the suggested tests and enters the disease prediction stage. The state transition
induced by the test suggestion is defined as
Ft+1 = Ft ∪W, st+1 = (Ft+1, x, t+ 1, edis).
The agent is required to predict the patient’s disease in the disease prediction stage edis. When the
agent predicts of the patient’s disease, the episode ends with a reward or a penalty. The agent arrives
at an artificial terminal state whenever the episode terminates.
Rewards. We define the reward functions of the disease prediction stage, medical test suggestion
stage, and symptom query stage in the following paragraphs. First, in the disease prediction stage,
the reward function consists of two components, prediction reward and abnormality reward. In order
to suggest medical tests that can maximize the disease-prediction accuracy, we design the prediction
reward to encourage the agent to predict correctly and punish it for predicting wrong. Assuming the
patient suffers from the disease y, and yˆ is the agent’s prediction, we define the prediction reward as
rpred(y, yˆ) =
{
m if y = yˆ,
−n otherwise, where m,n > 0.
The abnormality reward rab is designed to encourage the agent to explore present symptoms and
abnormal test results. Since a disease is usually reflected by symptoms and abnormal test results,
these abnormalities provide key information for disease diagnosis. Given a state s = (F , x, t, e), we
can compute the abnormality reward rab(s) by adding the number of known present symptoms and
the number of abnormal medical test results:
rab(s) = λ× |{f | f ∈ F ∩ (U ∪ V) and f(x) > 0}| ,
where λ is the weight of the rewards. In the disease prediction stage, given the agent’s disease
prediction a for a patient who suffers from disease y, our reward function in the disease prediction
stage is
r(s, a) = rpred(y, a) + rab(s).
Second, the reward function in the medical test suggestion stage consists of the medical test cost. It
attempt to balance the cost and effect of medical tests. In practice, given a disease, only particular
medical tests are critical; therefore, a good strategy is to suggest a compact set of medical tests which
is key to the diagnosis. Therefore, when the agent takes the actions Λ ⊆ Amed to suggests a set of
medical tests at a state s, we define the reward in the medical test suggestion stage as
r(s,Λ) = −c× |Λ|,
where c > 0 is the cost of each medical test. Note that we set the cost of all tests to be the same to
optimize patient benefits, not hospital profit.
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Third, in the symptom query stage, when the number of symptom queries is more than a predefined
number k, the agent is considered as failing to predict correctly. In this case, the training episode
terminates, and the agent receives a penalty of −n and the abnormality reward rab(s), where the
former agrees with the prediction reward and the latter guides the agent to explore key information.
Therefore, when the agent selects an action a ∈ Asym at a state s = (F , x, t, esym), the reward in the
disease prediction stage is defined as
r(s, a) =
{−n+ rab(s) if t ≥ k and a 6∈ {q1, q2},
0 otherwise.
3 Methodology
3.1 Neural Network Model of the Agent
s
pisym pimed pidis z
2048
1024
1024
Figure 1: Multi-task neural network.
We use a multi-task neural network to model the agent.
The input of the neural network considers the patient’s
information at a state s. We encode the patient’s in-
formation at the state as a vector in which each ele-
ment corresponds to a symptom, a medical test result,
or a demographic information item. Consider a state
s = (F , x, t, e) and an information item f ∈ V ∪ U
which is a symptom or a medical test result. If f is ob-
tainable at the state s, i.e. f ∈ F , the vector’s element
corresponding to f is set to f(x). Otherwise, the cor-
responding element is 0 to indicate that f is unknown.
On the other hand, we use the one-hot representation
to discretize the demographic information.
Given the patient’s information at a state, the network
generates three distributions pisym, pimed, and pidis to con-
struct the agent’s policy. These three distributions are
defined over the action sets Asym, Amed, and Adis re-
spectively. The network also outputs a vector z, which
is used in an auxiliary task described in Section 3.2.
The multi-task neural network comprises a shared input encoder and four decoders. Every encoder
and decoder is composed of two fully-connected layers. As depicted in Figure 1, a state s is encoded
into the hidden representation through the encoder, and the hidden representation is then decoded
into pisym, pimed, pidis, and z by their corresponding decoders. A rectifier non-linearity is used in all
layers except the output layers. We use the softmax function φ(x) = e
x∑n
j=1 e
xj in the decoders of
pisym and pidis. Note that we use the sigmoid function σ(x) = 11+e−x in the decoder of pimed, which
will be explained later. The sigmoid function is also used in the decoder of z because the auxiliary
task aims to predict a binary vector.
Although the network generates three distributions at each state, only the distribution over the valid
action set in the stage forms the agent’s policy. Specifically, given a state s = (F , x, t, e), we define
the agent’s policy at the state s as
pi(s, a) =

pisym(s, a) if e = esym,
pimed(s, a) if e = emed,
pidis(s, a) if e = edis.
Multiple Action Policy. In the typical RL setting, a single action is performed at each step. To
suggest a set of medical tests for a patient, we would like to perform multiple actions at once. A naive
method is to expand all combinatorial actions in Amed to the action space. This results in |2Amed |
actions, and the number of parameters blow up exponentially in terms of the size of the original
action space Amed. To achieve efficient multiple action selection, we need a compact representation
of pimed such that the parameters of pimed scales up linearly in terms of the size of Amed. We propose a
new representation of multiple action policy to solve this difficulty.
In the traditional setting, the softmax function is used in the output layer of pimed; in the multiple
action setting, we partition the policy pimed into pia, for each a ∈ Amed. We use the sigmoid function
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in the output layer of pia. Therefore, the output value of pia can be interpreted as the probability of
selecting an action a ∈ Amed. Using this new representation, the probability of selecting multiple
actions Λ ∈ 2Amed in a state s can be calculated by
pimed(s,Λ) =
∏
a∈Λ
pia(s)
∏
a6∈Λ
(1− pia(s)). (1)
Proposition 1. The multiple action policy pimed defined by Equation 1 satisfies∑
Λ∈2Amed
pimed(s,Λ) = 1 for all s.
Proposition 2. The set Λ of multiple actions which achieves the maximum probability in pimed can be
characterized by {
a ∈ Amed | pia(s) ≥ 1
2
}
∈ arg max
Λ∈2Amed
pimed(s,Λ).
Remark 1. The multiple action policy pimed is a legitimate probability distribution over action space
2Amed . While the size of action space is exponential in |Amed|, the parameters used in pimed only
scales up linearly in |Amed|. More importantly, selecting the best multiple actions from pimed can be
performed in linear time.
The proofs of Proposition 1 and 2 are available in the supplementary material.
3.2 Training of the Neural Network
We train our neural network with the policy-based REINFORCE method [11] to maximize the
expected total return Epi[
∑T
t=0 γ
trt]. We propose three techniques to improve training efficiency and
overall performance. We present these techniques first and then describe the objective function.
Multiple Action Sampling. Multiple action sampling can be performed using our new represen-
tation of policy pimed. To sample multiple actions from pimed, we can sample individual xa from
Bernoulli distributions pia, that is, xa ∼ pia for each a ∈ Amed. Then, by Equation 1, the multiple
actions Λ can be assembled from the individual sampled results xa, i.e., Λ = {a ∈ Amed | xa = 1}.
The new representation of our multiple action policy needs to be updated by gradient descent during
the REINFORCE algorithm. The traditional policy gradient is computed by
∇θEpi[R] ∝ Epi [∇θR log pi(s, a)] .
Therefore, the policy gradient used in our new representation pimed can be computed by
∇θR log pimed(s,Λ) = ∇θR log
∏
a∈Λ
pia(s)
∏
a6∈Λ
(1− pia(s))
=
∑
a∈Λ
∇θR log pia(s) +
∑
a6∈Λ
∇θR log(1− pia(s)).
Entropy Regularizer. We use the entropy regularizer [8, 12] to prevent the agent from converging
to sub-optimal policies. We compute the entropy H of the distributions pisym(s, ·) and pidis(s, ·)
by H(pi(s, ·)) = −∑a∈A pi(s, a) log pi(s, a). To compute the entropy of pimed, we can treat pia’s
as independent distributions (Equation 1). Therefore, by the property of the sum of individual
entropies [2], we have
H(pimed(s, ·)) = −
∑
a∈Amed
H(pia(s)).
Guiding Exploration with Disease Labels. We propose an exploration strategy called label-
guided exploration to speed up the learning process. In our training process, the agent needs to learn
the policy pisym of symptom queries, the policy pimed of test suggestions, and the disease distribution
pidis. However, in the RL setting, learning the distribution pidis is inefficient. To learn the distribution
pidis, the agent needs to predict a disease and update pidis based on the reward. Given that there are
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hundreds of possible diseases, the probability of exploring the correct label is quite low. To remedy
this problem, we can use the correct labels, which are available during our training process, to guide
the learning. At the disease prediction stage, with a probability of , we force the agent to choose the
correct label instead of the label sampled from pidis. This exploration scheme can accelerate policy
learning.
Although label-guided exploration is helpful in learning, a large  may degrade training performance.
The training of pisym and pimed aims to learn a policy that collects critical symptoms and test results
in order to differentiate between diseases. To achieve this, we need to evaluate the policy with the
agent’s predictions and update the policy accordingly. A large  will cause that most of the agent’s
predictions are ignored and replaced with the correct labels, leading to inaccurate policy evaluation.
This consequently impedes the training of pisym and pimed.
The probability  should be set to a reasonable value to train all the distributions pisym, pimed, and pidis.
In one extreme case where  is set to 1, the training of pidis is efficient, but the agent cannot learn pisym
and pimed. In contrast, setting  to too small a value diminishes the effect of label-guided exploration
and provide little help to the learning of pidis. The probability  of label-guided exploration balances
the training efficiency of pidis and the performance of pisym and pimed.
Training. The network is trained on two tasks: optimizing the agent’s policy and learning to
rebuild the patient’s full information. We impose the auxiliary task of rebuilding on the network
to learn the correlation between symptoms and medical test results [10]. Denote all symptoms by
f1, f2, ..., f|V| and all medical tests by f|V|+1, f|V|+2, ..., f|V|+|U|. Given a patient x, we define the
vector g ∈ {0, 1}|V|+|U| by
gi =
{
1 if fi(x) > 0,
0 otherwise.
The vector g marks the patient’s present symptoms and abnormal test results. Recall that the output
vector z in Figure 1 is generated for this auxiliary task. We train the network to rebuild g by the
output vector z. Given the output z and the the vector g, we define the rebuilding loss l(z,g) with
the binary cross entropy:
l(z,g) = −gᵀ log z− (1− g)ᵀ log(1− z).
Denote the parameters of our neural network by θ. We define the expected return Jret(θ), the entropy
regularizer Jent(θ), and the rebuilding loss Jreb(θ):
Jret(θ) = Epiθ
[
T∑
t=0
γtrt
]
, Jent(θ) = Epiθ
[
T∑
t=0
H(pi(st, ·))
]
, and Jreb(θ) = Epiθ
[
T∑
t=0
l(zt,g)
]
.
Therefore, we have the objective function
J(θ) = Jret(θ) + βJent(θ)− κJreb(θ),
where β and κ are hyperparameters. We update the network’s parameters with a learning rate α to
maximize the objective function J(θ).
4 Experiments
Table 1: The hyperparameters selected by
Hyperband.
Hyperparameter Value
Correct prediction reward m 0.8743
Wrong prediction reward n −0.7075
Medical test cost c −0.0084
Abnormality reward factor λ 0.1915
Entropy regularizer β 0.0117
Exploration factor  0.0056
To train an agent in our stage-wise sequential decision
problem, we simulate the symptoms, medical test re-
sults, and correct disease labels of patients. We synthe-
size our data according to a set of conditional probabil-
ity tables from hospital. These tables describe the con-
ditional probability distributions of the symptoms, de-
mographic information, and medical test results given
a patient’s disease. The disease labels of patients are
sampled first. We uniformly sample the patients’ dis-
eases to avoid data imbalance. Afterward, we sample
the symptoms, demographic information, and medical
test results of each patient from the conditional distribu-
tions given the disease label. We additionally sample a
present symptom of each patient as the initial symptom which is given to the agent at the initial state.
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All of our experiments are performed with the same settings. We use a simulated dataset of 106
patients for training and two different simulated datasets of 105 patients for validation and testing. We
use Adam [5] as our optimizer. The learning rate α is 10−4 and the batch size is 512. The parameter
for limiting the number of symptom queries k is 9. The discount factor γ is 0.99. The coefficient
of the rebuilding loss κ is 10. In additioin to these hyperparameters, we employ Hyperband [7]
to tune other critical hyperparameters including the prediction reward m,n, the cost c for each
medical test, the coefficient λ of the abnormality reward, and the  for label-guided exploration. The
hyperparameters selected by Hyperband are reported in Table 1.
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Figure 2: The training accuracy of our method (orange curve) and the baseline (blue line) on three
different datasets.
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Figure 3: The average number of medical test suggestions.
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Figure 4: The average number of abnormal test results.
To evaluate the extent to which a set of medical tests can help disease diagnosis, we perform three
experiments with 200, 300, and 400 diseases respectively, where the diseases are selected based on
the disease frequency. In these three experiments, we consider 36 common medical tests. We measure
the improvement in diagnosis accuracy given the set of medical tests. The accuracy improvement is
determined by the difference between two scenarios: (1) disease prediction with symptom queries
only, and (2) disease prediction with both symptom queries and medical test results. We report the
comparison of the training and test accuracy between the approaches where the medical test results
are and are not given. We also show the average number of medical test suggestions provided by our
approach.
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Table 2: The test accuracy of our method and baseline.
#Diseases Baseline Our method
Top 1 Top 3 Top 5 Top 1 Top 3 Top 5
200 54.69 74.63 80.88 64.74 83.74 89.75
300 48.28 67.31 74.04 56.18 77.05 84.87
400 42.82 59.49 65.60 49.83 71.09 79.73
Table 3: The statistics of medical test suggestions.
#Diseases Suggestion Ratio (%) #Suggested Tests Abnormality Discovery Ratio (%)
200 47.59 4.77 92.81
300 43.40 4.31 91.22
400 35.60 6.03 73.70
Figure 2 shows the comparison of the disease diagnosis accuracy between the baseline and our
proposed method during training. We use REFUEL [10] as the baseline algorithm, which is the
state-of-the-art diagnosis model without considering medical test information. In Figure 2, the x-axis
is the training epoch and the y-axis is the training accuracy. The orange curve is the average training
accuracy of our method over five different random seeds, and the shaded area represents two standard
deviations. The blue line is the performance of the baseline algorithm. We observe that the training
accuracy of our proposed method (with medical test suggestion) outperforms the baseline by about
10% in all cases.
Next, we investigate the agent’s behavior of medical test suggestions during training. Figure 3 shows
the average number of suggested medical tests provided by the agent. We can see that the average
number of suggested medical tests decreases over time. Figure 4 indicates the number of abnormal
medical test results, which sharply increases at the beginning of the training process and then is
sustained. Considering both figures, we conclude that the agent can learn to avoid suggesting too
many medical tests and suggest only critical ones.
To measure the performance of our proposed method after training, we select the models based on the
validation set and evaluate them on the testing set. Table 2 shows the test accuracy. The test accuracy
reported in Table 2 are averaged over five different random seeds. The test results indicate that our
method outperforms the baseline in all cases. Concretely, we observe a 7%-14% improvement when
we consider medical test suggestions.
In Table 3, the suggestion ratio is the probability that the agent provides medical test suggestions for
a patient; the number of suggested tests is the average number of the suggested tests of a patient; the
abnormality discovery ratio is the ratio of the number of abnormal test results discovered by the agent
to the total number of abnormal test results from our dataset. In our experiments, we consider 36
medical tests. The agent chooses to suggest medical tests with a probability around 35-48% because
not every patient needs medical tests. When the agent suggests medical tests, it suggests 4-6 medical
tests on average. The tests suggested by the agent can discover over 90% of abnormalities in the cases
of 200 and 300 diseases. Therefore, we conclude that our agent can suggest critical medical tests.
5 Conclusions
In this work, we demonstrated that an agent can learn to suggest medical tests to facilitate disease
diagnosis. We formulated the problem as a stage-wise Markov decision process and proposed a
reinforcement learning method for training the agent. We introduced a new multiple action policy
representation along with the training method of the proposed representation. Furthermore, a new
exploration scheme was proposed to accelerate the learning of disease distributions. Our experimental
results showed that the accuracy of disease diagnosis can be significantly improved with medical
tests.
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A Proofs of Propositions
Recall that we define a multiple action policy over the action set A as
pi(s,Λ) =
∏
a∈Λ
pia(s)
∏
a∈A\Λ
(1− pia(s)). (2)
Then, we have two propositions.
Proposition 1. The multiple action policy pi defined by Equation 2 satisfies∑
Λ∈2A
pi(s,Λ) = 1 for all s.
Proposition 2. The set Λ of multiple actions which achieves the maximum probability in pi can be
characterized by {
a ∈ A | pia(s) ≥ 1
2
}
∈ arg max
Λ∈2A
pi(s,Λ).
Here we give the proofs of Proposition 1 and 2.
A.1 Proof of Proposition 1
We prove this proposition by induction. Consider the case A = {b}. We have∑
Λ∈2A
pi(s,Λ) =
∑
Λ∈{∅,{b}}
pi(s,Λ)
=
∏
a∈∅
pia(s)
∏
a∈{b}
(1− pia(s)) +
∏
a∈{b}
pia(s)
∏
a∈∅
(1− pia(s))
= 1− pib(s) + pib(s)
= 1.
Assuming that the statement holds given a set of actions A, we show that the statement holds on the
set A′ = A ∪ {b}.∑
Λ∈2A′
pi(s,Λ) =
∑
Λ∈2A′
∏
a∈Λ
pia(s)
∏
a∈A′\Λ
(1− pia(s))
=
∑
Λ∈2A′ ,b∈Λ
∏
a∈Λ
pia(s)
∏
a∈A′\Λ
(1− pia(s)) +
∑
Λ∈2A′ ,b 6∈Λ
∏
a∈Λ
pia(s)
∏
a∈A′\Λ
(1− pia(s))
= pib(s)
 ∑
Λ∈2A
∏
a∈Λ
pia(s)
∏
a∈A\Λ
(1− pia(s))
+ (1− pib(s))
 ∑
Λ∈2A
∏
a∈Λ
pia(s)
∏
a∈A\Λ
(1− pia(s))

= pib(s)
∑
Λ∈2A
pi(s,Λ) + (1− pib(s))
∑
Λ∈2A
pi(s,Λ)
= pib(s) + (1− pib(s))
= 1.
A.2 Proof of Proposition 2
Define the set Λ∗ ⊆ A of multiple actions as
Λ∗ =
{
a ∈ A | pia(s) ≥ 1
2
}
.
Given a set Λ ∈ 2A, we use the notation Λ to denote A \ Λ. By the definition of Λ∗, we know that
∀a ∈ Λ∗.
[
pia(s) ≥ 1
2
≥ 1− pia(s)
]
, and
∀a ∈ Λ∗.
[
pia(s) <
1
2
< 1− pia(s)
]
.
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Considering a set Λ ∈ 2A, we show that
pi(s,Λ∗) =
∏
a∈Λ∗
pia(s)
∏
a∈Λ∗
(1− pia(s))
=
∏
a∈Λ∗∩Λ
pia(s)
∏
a∈Λ∗∩Λ
pia(s)
∏
a∈Λ∗ ∩Λ
(1− pia(s))
∏
a∈Λ∗ ∩Λ
(1− pia(s))
≥
∏
a∈Λ∗∩Λ
pia(s)
∏
a∈Λ∗∩Λ
(1− pia(s))
∏
a∈Λ∗ ∩Λ
pia(s)
∏
a∈Λ∗ ∩Λ
(1− pia(s))
=
∏
a∈Λ∗∩Λ
pia(s)
∏
a∈Λ∗ ∩Λ
pia(s)
∏
a∈Λ∗∩Λ
(1− pia(s))
∏
a∈Λ∗ ∩Λ
(1− pia(s))
=
∏
a∈Λ
pia(s)
∏
a∈Λ
(1− pia(s))
= pi(s,Λ).
Since pi(s,Λ∗) ≥ pi(s,Λ), for all Λ ∈ 2A, we have Λ∗ ∈ arg max
Λ∈2A
pi(s,Λ).
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